Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Leukocytes01:27

Disorders of Leukocytes

1.8K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.8K
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

14.5K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
14.5K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

8.3K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
8.3K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

15.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
15.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endosteal integrin-α8⁺ mesenchymal stem cells maintain haematopoietic stem cell function via extracellular matrix-mediated interactions.

Nature communications·2026
Same author

TP-0903 Suppresses Aurora A-PLK1 Signaling to Inhibit Proliferation of a Myelodysplastic Syndrome-Derived Cell Line.

Cancer science·2025
Same author

Acute myeloid leukemia stem cells remodel the bone marrow niche via TGF-β-activated Alcam<sup>+</sup> bone lining cells, creating a self-sustaining environment.

Leukemia·2025
Same author

POT1a deficiency in mesenchymal niches perturbs B-lymphopoiesis.

Communications biology·2023
Same author

Pan-PI3Ki targets multiple B-ALL microenvironment interactions that fuel systemic and CNS relapse.

Leukemia & lymphoma·2021
Same author

Mitochondrial Protein Synthesis Is Essential for Terminal Differentiation of CD45<sup>-</sup> TER119<sup>-</sup>Erythroid and Lymphoid Progenitors.

iScience·2020

Related Experiment Video

Updated: Jan 6, 2026

Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

9.5K

[Central nervous system involvement in acute lymphoblastic leukemia].

Hisayuki Yao1

  • 1Department of Cancer Stem Cell and Medicine, Graduate School of Medical Science, Kyushu University.

[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|October 11, 2019
PubMed
Summary

Researchers found acute lymphoblastic leukemia (ALL) cells invade the central nervous system (CNS) via blood vessels. A PI3Kδ inhibitor reduced invasion by blocking integrin α6, offering a potential treatment for CNS leukemia.

Keywords:
Integrin α6LamininPI3Kδ

More Related Videos

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

508
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.7K

Related Experiment Videos

Last Updated: Jan 6, 2026

Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

9.5K
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

508
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.7K

Area of Science:

  • Hematology
  • Neuro-oncology
  • Molecular Biology

Background:

  • Acute lymphoblastic leukemia (ALL) cells are known to infiltrate the central nervous system (CNS).
  • The precise mechanisms driving CNS invasion by ALL cells remain largely unknown.
  • Understanding these pathways is crucial for developing targeted therapies.

Purpose of the Study:

  • To elucidate the direct routes and molecular mechanisms of ALL cell migration into the CNS.
  • To investigate the role of specific molecular interactions in mediating CNS invasion.
  • To evaluate the therapeutic potential of targeting identified pathways.

Main Methods:

  • Utilized a murine model of ALL to observe cell migration patterns.
  • Analyzed the interaction between ALL cells, bridging vessels, and the extracellular matrix component laminin.
  • Investigated the role of integrin α6 and its dependence on PI3Kδ activity.
  • Administered a PI3Kδ inhibitor to ALL xenograft mice and assessed therapeutic efficacy.

Main Results:

  • Identified direct migration routes of ALL cells along bridging vessels from bone marrow to the subarachnoid space.
  • Demonstrated that laminin in the vessel basement membrane interacts with ALL cell integrin α6, mediating invasion.
  • Showed that integrin α6 expression is regulated by PI3Kδ activity.
  • PI3Kδ inhibition significantly reduced CNS leukemic burden and symptoms in mice.

Conclusions:

  • ALL cell CNS invasion is facilitated by migration along specific vascular routes.
  • The laminin-integrin α6 interaction, dependent on PI3Kδ, is a key mediator of this invasion.
  • Targeting PI3Kδ shows promise as a strategy to prevent or treat CNS involvement in ALL.